Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.49% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NKTR · Dec 31, 2024
NEKTAR THERAPEUTICS. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-25-039389General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-178.52% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
9.22% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
0.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
68.82% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-106.88% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
122.84% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
21.96% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History12 statesHistory building
Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 2.76%
- Current
- 1.49%
- Delta
- -1.27%
- Previous
- -182.11%
- Current
- -178.52%
- Delta
- 3.59%
- Previous
- -0.08%
- Current
- 9.22%
- Delta
- 9.30%
- Previous
- 81.62%
- Current
- 68.82%
- Delta
- -12.79%
- Previous
- -142.37%
- Current
- -106.88%
- Delta
- 35.49%
- Previous
- 145.21%
- Current
- 122.84%
- Delta
- -22.37%
- Previous
- 22.35%
- Current
- 21.96%
- Delta
- -0.39%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · NKTR Fundamental State →Has State · NEKTAR THERAPEUTICS →Transitioned To · NKTR CASH_GENERATION_INCREASED →Transitioned To · NKTR MARGIN_DECREASED →Transitioned To · NKTR PROFITABILITY_INCREASED →Transitioned To · NKTR R_AND_D_INTENSITY_DECREASED →Transitioned To · NKTR SBC_INTENSITY_DECREASED →Transitioned To · NKTR Fundamental State →Transitioned To · NKTR CAPEX_INTENSITY_DECREASED →Transitioned To · NKTR GROWTH_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.